Please use this identifier to cite or link to this item: http://hdl.handle.net/2445/193132
Title: Rationale and design of the Concordance study between FFR and iFR for the assessment of lesions in the left main coronary artery. The ILITRO-EPIC-07 Trial
Author: Rodríguez Leor, Oriol
Torre Hernández, José M. de la
García Camarero, Tamara
López Palop, Ramón
García del Blanco, Bruno
Carrillo, Xavier
Portero Portaz, Juan José
Jiménez Kockar, Marcelo
Gómez Lara, Josep
Ojeda, Soledad
Alfonso, Fernando
Brugaletta, Salvatore
Planas del Viejo, Ana
Linares, José Antonio
Fernández Cisnal, Agustín
Vaquerizo, Beatriz
Fernández Salinas, Francisco
Díaz Fernández, José Francisco
Rama Merchán, Juan Carlos
Molina, Eduardo
Muñoz García, Érika
Morales, Francisco
Trillo, Ramiro
Tellería, Miren
Rondán, Juan
Avanzas, Pablo
Moreu, José
Baz Alonso, José Antonio
Hernández, Felipe
Escaned, Javier
Sanchis, Juan
Lozano, Fernando
Toledano, Beatriz
Puigfel, Martí
Sádaba, Mario
Pérez de Prado, Armando
Keywords: Assaigs clínics
Artèries coronàries
Estenosi
Clinical trials
Coronary arteries
Stenosis
Issue Date: 9-Aug-2021
Publisher: Publicidad Permanyer, SLU
Abstract: Introduction and objectives: Patients with left main coronary artery (LMCA) stenosis have been excluded from the trials that support the non-inferiority of the instantaneous wave-free ratio (iFR) compared to the fractional flow reserve (FFR) in the decision-making process of coronary revascularization. This study proposes to prospectively assess the concordance between the two indices in LMCA lesions and to validate the iFR cut-off value of 0.89 for clinical use. Methods: National, prospective, and observational multicenter registry of 300 consecutive patients with intermediate lesions in the LMCA (angiographic stenosis, 25% to 60%. A pressure gudiewire study and determination of the RFF and the iFR will be performed: in the event of a negative concordant result (FFR > 0.80/iFR > 0.89), no treatment will be performed; in case of a positive concordant result (FFR <= 0.80/iFR <= 0.89), revascularization will be performed; In the event of a discordant result (FFR> 0.80/iFR <= 0.89 or FFR <= 0.80/iFR> 0.89), an intravascular echocardiography will be performed and revascularization will be delayed if the minimum lumen area is > 6 mm(2). The primary clinical endpoint will be a composite of cardiovascular death, LMCA lesion-related non-fatal infarction or need for revascularization of the LMCA lesion at 12 months. Conclusions: Confirm that an iFR-guided decision-making process in patients with intermediate LMCA stenosis is clinically safe and would have a significant clinical impact. Also, justify its systematic use when prescribing treatment in these potentially high-risk patients.
Note: Reproducció del document publicat a: https://doi.org/10.24875/RECICE.M21000227
It is part of: REC: interventional cardiology (English Edition), 2022, vol. 4, num. 1, p. 19-26
URI: http://hdl.handle.net/2445/193132
Related resource: https://doi.org/10.24875/RECICE.M21000227
ISSN: 2604-7322
Appears in Collections:Articles publicats en revistes (Institut d'lnvestigació Biomèdica de Bellvitge (IDIBELL))

Files in This Item:
File Description SizeFormat 
05_recic_21_027_rodriguez_ao_uktrad.pdf314.61 kBAdobe PDFView/Open


This item is licensed under a Creative Commons License Creative Commons